Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D 2 /D 3 Selective Receptor Antagonist for the Management of Gastroparesis

Gastroparesis is characterized by delayed gastric emptying in the absence of mechanical obstruction. Owing to the potential for serious side effects, current treatments have restrictions on their use and there is a need for novel compounds with favorable safety profiles. Trazpiroben (previously TAK-...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of experimental pharmacology 2022, Vol.14, p.43
Hauptverfasser:	Kreckler, Laura, Osinski, Mark, Williams, Scott, Whiting, Roger
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!